Achilles Therapeutics Companies
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues.
Investors
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
United States
Founded Date:
2016
Register and Claim Ownership